uniQure Gets Orphan Medicinal Product Designation for Huntington’s Gene Therapy – Labiotech.eu (blog)
Labiotech.eu (blog) |
uniQure Gets Orphan Medicinal Product Designation for Huntington's Gene Therapy
Labiotech.eu (blog) The EMA has given uniQure's gene therapy candidate for Huntington's disease Orphan Medicinal Product Designation, which the company hopes to move into the clinic this year. uniQure is known for Glybera, Europe's first gene therapy. The company's … |
